av/altamira-therapeutics--big.svg

NASDAQ:EARS

Altamira Therapeutics Ltd.

  • Stock

USD

Last Close

0.91

30/08 20:00

Market Cap

2.89M

Beta: 1.40

Volume Today

37.01K

Avg: 1.89M

PE Ratio

−0.05

PFCF: −0.22

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
395.53K
-
411.62K
4.07%
-119.37K
129.00%
-232.83K
95.06%
-39.92K
82.85%
-79.94K
100.25%
-494.29M
618,220.74%
-673.33M
36.22%
-178.67M
73.47%
425.43K
100.24%
5.82K
98.63%
average payables
678.14K
-
2.09M
208.21%
2.22M
6.21%
1.47M
33.80%
1.47M
0.18%
1.52M
3.51%
1.39M
8.65%
850.35K
38.70%
2.15M
153.24%
4.16M
93.00%
2.59M
37.67%
average receivables
94.69K
-
308.29K
225.59%
597K
93.65%
433.82K
27.33%
228.96K
47.22%
280.83K
22.66%
327.84K
16.74%
208.08K
36.53%
510.22K
145.20%
851.05K
66.80%
418.67K
50.81%
book value per share
2.00K
-
7.70K
284.50%
5.54K
28.00%
1.65K
70.26%
-197.73
112.00%
91.81
146.43%
41.50
54.80%
55.77
34.38%
19.18
65.60%
-9.13
147.60%
capex per share
-24.14
-
-178.90
641.13%
-9.90
94.47%
-28.47
187.61%
-13.99
50.86%
-47.57
240.07%
-20.75
56.38%
-7.70
62.90%
-5.02
34.78%
-2.35
53.15%
capex to depreciation
-2.90
-
-16.74
476.52%
-0.86
94.85%
-2.50
190.60%
-1.25
50.23%
-26.01
1,987.59%
-97.93
276.56%
-115.55
17.99%
-43.56
62.31%
-18.02
58.62%
capex to operating cash flow
0.01
-
0.06
726.58%
0.00
95.66%
0.01
198.17%
0.01
24.04%
0.14
2,168.07%
0.36
151.64%
0.48
32.91%
0.24
49.11%
0.25
1.45%
capex to revenue
-0.41
-
1.19
389.81%
0.59
50.53%
-0.48
180.50%
-1.49
214.44%
53.90
3,708.60%
-13.27
124.62%
-52.06
292.35%
-7.01
86.53%
cash per share
5.29K
-
8.22K
55.51%
6.22K
24.34%
3.78K
39.24%
1.37K
63.78%
135.67
90.09%
9.52
92.98%
37.44
293.29%
1.49
96.03%
0.02
98.86%
days of inventory on hand
136.71
-
2.94
97.85%
days payables outstanding
577.40
-
1.21K
108.75%
days sales outstanding
65.87
-
-3.55K
5,484.29%
-190.99
94.61%
273.50
243.20%
92.37
66.23%
-2.19K
2,466.03%
169.16
107.74%
5.37K
3,073.58%
910.68
83.04%
debt to assets
0.52
-
0.35
-
0.57
63.83%
0.15
74.42%
0.03
-
0.03
21.33%
1.00
3,186.89%
0.01
98.71%
debt to equity
1.52
-
0.87
-
-4.68
635.71%
0.39
108.40%
0.03
-
0.05
45.05%
-0.76
1,780.25%
0.02
102.03%
dividend yield
earnings yield
-0.16
-
-0.17
8.84%
-0.19
12.78%
-0.82
329.34%
-0.97
18.64%
-1.61
66.23%
-1.45
9.87%
-0.59
59.37%
-0.79
34.10%
-6.50
720.81%
enterprise value
86.59M
-
50.79M
41.34%
105.80M
108.29%
17.44M
83.52%
20.32M
16.57%
3.17M
84.38%
3.18M
0.19%
3.16M
0.75%
21.56M
583.07%
10.40M
51.77%
-517.75K
104.98%
enterprise value over ebitda
-5.97
-
-2.29
61.66%
-3.43
49.88%
-0.58
83.09%
-0.84
44.14%
-0.29
65.34%
-0.44
51.56%
-0.60
36.04%
-1.27
112.02%
-0.40
68.44%
ev to operating cash flow
-6.17
-
-2.63
57.35%
-3.68
40.05%
-0.59
83.93%
-0.84
41.43%
-0.24
71.35%
-0.38
57.95%
-0.65
71.99%
-1.58
141.97%
-1.20
24.05%
0.04
103.76%
ev to sales
16.88
-
-1.58K
9,454.34%
-42.11
97.33%
63.12
249.87%
2.51
96.03%
-56.79
2,365.02%
18.09
131.85%
337.48
1,765.61%
34.02
89.92%
free cash flow per share
-3.14K
-
-2.97K
5.32%
-3.57K
20.17%
-3.46K
3.01%
-2.23K
35.44%
-380.44
82.97%
-78.46
79.38%
-23.81
69.66%
-25.67
7.81%
-11.89
53.68%
free cash flow yield
-0.15
-
-0.19
30.43%
-0.18
3.24%
-0.79
328.80%
-0.97
22.59%
-2.12
118.49%
-2.50
17.90%
-0.52
79.39%
-0.77
50.16%
-2.65
242.68%
graham net net
1.55K
-
7.40K
377.18%
5.25K
29.02%
1.29K
75.41%
-445.73
134.49%
-15.94
96.42%
-3.41K
21,281.05%
-571.31
83.24%
-6.08
98.94%
-15.40
153.36%
graham number
12.24K
-
21.33K
74.29%
21.42K
0.42%
11.51K
46.26%
3.15K
72.62%
772.93
75.47%
206.33
73.30%
184.98
10.35%
106.45
42.45%
77.35
27.33%
income quality
0.94
-
1.06
13.49%
0.97
8.95%
0.96
0.67%
0.99
3.53%
1.15
15.73%
1.27
9.96%
0.59
53.33%
0.79
33.11%
0.33
58.37%
2.98
808.92%
intangibles to total assets
0.06
-
0.02
55.86%
0.03
12.65%
0.04
48.06%
0.09
119.81%
0.36
291.66%
0.73
104.87%
0.44
40.24%
0.76
73.39%
0.62
18.70%
0.51
18.08%
interest coverage
-291.29
-
-447.14
53.51%
-3.86K
763.20%
-36.48
99.05%
-14.85
59.29%
-10.24
31.08%
-253.57
2,377.26%
-39.09
84.58%
-90.14
130.60%
-28.66
68.21%
interest debt per share
3.05K
-
7.17
99.76%
0.99
86.18%
1.54K
155,047.80%
1.08K
30.00%
63.03
94.14%
0.20
99.69%
2.19
1,013.57%
1.16
47.27%
7.95
588.18%
inventory turnover
2.67
-
124.00
4,544.54%
invested capital
1.52
-
0.87
-
-4.68
635.71%
0.39
108.40%
0.03
-
0.05
45.05%
-0.76
1,780.25%
0.02
102.03%
market cap
96.74M
-
107.73M
11.35%
156.03M
44.84%
37.51M
75.96%
25.17M
32.90%
7.13M
71.67%
4.56M
35.99%
13.89M
204.31%
21.97M
58.14%
4.08M
81.41%
net current asset value
7.36M
-
51.53M
600.62%
43.00M
16.56%
12.18M
71.68%
-4.12M
133.84%
-162.35K
96.06%
-816.15K
402.71%
7.59M
1,029.71%
-2.37M
131.29%
-12.85M
441.18%
-12.39K
99.90%
net debt to ebitda
0.70
-
2.57
266.49%
1.63
36.50%
0.67
58.99%
0.20
70.15%
0.36
81.20%
0.19
47.07%
2.03
962.62%
0.02
98.82%
-0.24
1,111.75%
net income per share
-3.32K
-
-2.63K
20.99%
-3.68K
40.06%
-3.57K
2.89%
-2.23K
37.52%
-289.20
87.04%
-45.60
84.23%
-27.27
40.19%
-26.26
3.71%
-29.13
10.94%
operating cash flow per share
-3.11K
-
-2.79K
10.34%
-3.56K
27.52%
-3.43K
3.54%
-2.22K
35.31%
-332.87
85.01%
-57.71
82.66%
-16.11
72.09%
-20.64
28.17%
-9.53
53.81%
payables turnover
0.63
-
0.30
52.10%
receivables turnover
5.54
-
-0.10
101.86%
-1.91
1,756.89%
1.33
169.83%
3.95
196.10%
-0.17
104.23%
2.16
1,391.93%
0.07
96.85%
0.40
489.50%
research and ddevelopement to revenue
5.88
-
-396.06
6,831.49%
-59.85
84.89%
59.66
199.69%
5.28
91.14%
-59.38
1,223.76%
16.41
127.63%
139.93
752.76%
64.39
53.99%
return on tangible assets
-0.61
-
-0.31
48.25%
-0.58
84.61%
-0.90
55.04%
-1.51
67.97%
-1.81
20.29%
-2.70
48.68%
-0.70
73.96%
-3.84
447.74%
-11.01
186.45%
revenue per share
434.64
-
-8.30
101.91%
-48.24
481.33%
29.45
161.04%
31.85
8.15%
-0.39
101.21%
0.58
250.70%
0.10
83.38%
0.34
247.92%
roe
-1.66
-
-0.34
79.45%
-0.66
94.53%
-2.17
226.55%
11.29
620.71%
-3.15
127.90%
-1.10
65.12%
-0.49
55.49%
-1.37
179.93%
3.19
333.08%
roic
-0.66
-
-0.40
39.62%
-0.69
73.74%
-1.14
64.98%
-3.06
169.22%
-2.19
28.52%
-1.17
46.52%
-0.30
73.92%
-1.24
305.52%
17.16
1,488.96%
sales general and administrative to revenue
1.49
-
-64.81
4,443.98%
-13.07
79.83%
16.00
222.35%
3.37
78.94%
-70.25
2,185.42%
14.87
121.17%
76.64
415.34%
11.52
84.96%
shareholders equity per share
2.00K
-
7.70K
284.50%
5.54K
28.00%
1.65K
70.26%
-197.73
112.00%
91.81
146.43%
41.50
54.80%
55.77
34.38%
19.18
65.60%
-9.13
147.60%
stock based compensation to revenue
0.09
-
-4.65
5,269.88%
-0.70
84.90%
1.10
256.90%
0.02
98.01%
-4.05
18,573.86%
2.11
152.24%
18.88
793.36%
1.12
94.06%
tangible asset value
7.55M
-
51.80M
585.99%
43.26M
16.49%
12.66M
70.73%
-3.79M
129.95%
114.41K
103.02%
-729.48K
737.60%
7.65M
1,149.31%
-1.61M
121.04%
-12.21M
658.13%
2.57M
121.01%
tangible book value per share
1.67K
-
7.48K
347.19%
5.36K
28.39%
1.48K
72.47%
-346.71
123.50%
2.88
100.83%
-5.02
274.26%
25.45
607.55%
-2.43
109.55%
-13.41
451.34%
working capital
8.01M
-
53.30M
565.36%
44.90M
15.76%
24.73M
44.92%
5.44M
78.00%
1.50M
72.39%
95.80K
93.62%
8.59M
8,864.26%
-1.10M
112.82%
-11.11M
909.47%
334.24K
103.01%

All numbers in USD (except ratios and percentages)